Mesenchymal stem cells (MSCs) are ideal for cell-based therapy in various inflammatory
diseases because of their immunosuppressive and tissue repair properties. Moreover, their …

Mesenchymal stem cells (MSCs) are currently being widely investigated both in the lab and
in clinical trials for multiple disease states. The differentiation, trophic, and …

The concept of mesenchymal stem cells (MSCs) is becoming increasingly obscure due to
the recent findings of heterogeneous populations with different levels of stemness within …

Mesenchymal stem cells (MSCs) can exhibit a marked tropism towards site of tumors. Many
studies have reported that tumor progression and metastasis increase by MSCs. In contrast …

Stem cells have the capacity for self-renewal and differentiation into specialized cells that
form and repopulated all tissues and organs, from conception to adult life. Depending on …

The strategy of using mesenchymal stem cells (MSCs) as a living carrier for active delivery of
therapeutic agents targeting tumor sites has been attempted in a wide range of studies to …

Cell therapies are increasingly recognized as a promising option to augment the limited
therapeutic arsenal available to fight ischemic stroke. During the last two decades …

We sought to assess whether the effects of mesenchymal stromal cells (MSC) on lung
inflammation and remodeling in experimental emphysema would differ according to MSC …

Progress in genetic engineering led to the emergence of some viruses as potent anticancer
therapeutics. These oncolytic viruses combine self-amplification with dual antitumor action …

The acute respiratory distress syndrome (ARDS) is a multifaceted lung disorder in which no
specific therapeutic intervention is able to effectively improve clinical outcomes. Despite an …